The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of AstraZeneca Plc’s (NASDAQ:AZN) Ultomiris (ravulizumab)…
O2Micro International Limited (NASDAQ Global Select Market: OIIM) ("O2Micro" or the "Company"), a global leader in the design, development and marketing of high-performance integrated circuits and